In partnership with NYC Health + Hospitals, BioReference is expanding access to COVID-19 antibody testing ELMWOOD PARK, N.J., May 8, 2020 – BioReference Laboratories, Inc., an OPKO Health company (NASDAQ:OPK), today announced the launch of COVID-19 antibody screening available to New York City residents in partnership with New York City Health and Hospital Corporation (NYC Health […]
Search Results for: NYC
NYC Press Office Appointment-only antibody testing will be offered in Morrisania, East New York, Upper Manhattan, Concord, and Long Island City beginning next week NEW YORK—Mayor Bill de Blasio today announced expanded antibody testing for New Yorkers. Through a partnership with BioReference labs, the City will conduct its own antibody survey at community testing sites in the five boroughs […]
New York State’s Website New York State is Now Conducting Average of 30,000 Diagnostic Tests Per Day Results of FDNY and NYPD Antibody Testing Study Show 17.1 Percent of FDNY and 10.5 Percent of NYPD Have Antibodies State is Expanding Antibody Testing Today for 1,000 Transit Workers Directs MTA to Issue Full Plan by Tomorrow […]
Press Release
OPKO Health’s BioReference Laboratories Partners with Hospitals Nationwide to Provide Prioritized Testing to Inpatients with Suspected Coronavirus Disease 2019 (COVID-19)
06
Apr
Apr
ELMWOOD PARK, N.J., April 6, 2020 /PRNewswire/ — BioReference Laboratories, Inc., an OPKO Health company (NASDAQ: OPK), today announced that it will continue to prioritize COVID-19 testing for hospital inpatients and critically ill patients around the country. “Our goal is to maintain the current 24 hour turnaround time for these patients,” said Jon R. Cohen, M.D., Executive Chairman of […]
Press Release
OPKO Health’s BioReference Laboratories and City of Miami Provide Testing for Coronavirus Disease 2019 (COVID-19)
24
Mar
Mar
BioReference will offer COVID-19 testing for public drive-through facilities for Miami residents and Larkin Community Hospital ELMWOOD PARK, N.J., March 24, 2020 – BioReference Laboratories, Inc., an OPKO Health company (NASDAQ: OPK), today announced a collaboration with the City of Miami to provide coronavirus disease 2019 (COVID-19) testing. BioReference will provide COVID-19 testing at drive-through locations […]
Press Release
OPKO Health’s BioReference Laboratories and City of Detroit Provide Testing for Coronavirus Disease 2019 (COVID-19)
23
Mar
Mar
BioReference will offer COVID-19 testing for public drive-through facilities for Detroit residents ELMWOOD PARK, N.J., March 23, 2020 /PRNewswire/ — BioReference Laboratories, Inc., an OPKO Health company (NASDAQ: OPK), today announced a collaboration with the City of Detroit to provide coronavirus disease 2019 (COVID-19) testing. BioReference will provide COVID-19 testing at drive-through locations for Detroit residents by appointment. “The impact that expanded testing will […]
Press Release
OPKO Health’s BioReference Laboratories and State of New Jersey Provide Testing for Coronavirus Disease 2019 (COVID-19)
20
Mar
Mar
BioReference offers COVID-19 testing for first five NJ drive-through testing facilities in the counties of Burlington, Essex, Hudson, Ocean and Union BioReference to participate in NJ press conference on Friday, March 20 at 2:00 p.m. ET ELMWOOD PARK, N.J., March 20, 2020 – BioReference Laboratories, Inc., an OPKO Health company (NASDAQ: OPK), today announced a collaboration […]
Study of 11,506 men shows that healthy men with an abnormal PSA and a low 4Kscore test result can be safely monitored rather than undergo prostate biopsy MIAMI, March 16, 2018 (GLOBE NEWSWIRE) — OPKO Health, Inc.(NASDAQ:OPK) today announced that data from a landmark study of the 4Kscore® test entitled, “Twenty-year Risk of Prostate Cancer Death by Midlife Prostate-specific Antigen and a Panel […]
- 1
- 2
